Immediate Impact

58 standout
Sub-graph 1 of 24

Citing Papers

Construction of enzymatic crosslinking beta-lactoglobulin-camellia oil emulsion gels: Microstructural characterization, stability, and curcumin delivery behavior
2025 Standout
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies
2025 Standout
2 intermediate papers

Works of Mostafa Dastani being referenced

Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial
2022
The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial.
2016

Author Peers

Author Last Decade Papers Cites
Mostafa Dastani 23 165 40 90 64 21 353
Vânia Ortega Gutierres 10 150 21 127 62 10 359
Jessica J. A. Ferguson 17 87 22 67 108 25 397
Weerapon Sangartit 34 51 31 57 71 20 349
Rania F. Ahmed 1 61 56 50 49 31 374
Patrícia Cincotto dos Santos Bueno 4 53 29 66 105 30 332
Mehdi Zobeiri 3 134 89 41 50 9 345
Mohammad Jalali 6 45 114 107 57 25 389
Bijan Helli 14 38 71 46 47 23 342
Faeze Keihanian 31 129 38 35 34 27 350
Hamid Ghalandari 17 60 58 69 123 33 328

All Works

Loading papers...

Rankless by CCL
2026